#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12060	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2048	580.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	677	C	668	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12060	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2048	580.1	0	HET	.	.	.	T1412TGGGGG,TGGGGGG,TGGGGGGG	.	1412	1412	T	1643	1643	T	683	TGGGGG,TGGGGGG,TGGGGGGG	501,130,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12060	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2048	580.1	0	HET	.	.	.	C1525T	.	1525	1525	C	1756	1756	C	565	C,T	427,120	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	0	.	n	.	0	T695C	SNP	695	695	T	934	934	C	649	C,T	636,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	0	.	n	.	0	T1269C	SNP	1269	1269	T	1508	1508	C	675	C,T,A	593,31,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	1877	1877	G	663	G,A	624,24	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2210	2210	C	626	C	610	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2284	2284	A	662	A	653	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21650	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3373	634.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2836	2836	C	676	C,T,A	641,20,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1626	folP	855	855	100.0	folP.l15.c4.ctg.1	1397	114.8	1	SNP	p	R229S	1	.	.	685	687	AGC	981	983	AGC	180;180;181	A,T;G;C	173,1;175;174	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	139.0	1	SNP	p	S91F	1	.	.	271	273	TTC	588	590	TTC	174;174;177	T,A;T,C;C	172,2;167,7;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	139.0	1	SNP	p	G95N	0	.	.	283	285	GGC	600	602	GGC	184;186;190	G;G,A;C,G	182;175,7;187,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4730	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	139.0	1	SNP	p	D95G	1	.	.	283	285	GGC	600	602	GGC	184;186;190	G;G,A;C,G	182;175,7;187,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1428	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1314	107.6	0	.	p	.	0	F184L	NONSYN	550	552	TTC	913	915	TTG	163;163;163	T;T,C;G,C,A	159;157,1;152,10,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1428	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1314	107.6	1	SNP	p	G45D	0	.	.	133	135	GGC	496	498	GGC	172;172;174	G;G;C	168;164;172	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	806	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	990	80.5	0	.	n	.	0	A197.	DEL	197	197	A	553	553	A	189	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3099	137.2	1	SNP	p	D86N	0	.	.	256	258	GAC	621	623	GAC	170;167;168	G;A;C	168;161;165	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3099	137.2	1	SNP	p	S87R	1	.	.	259	261	CGT	624	626	CGT	169;168;169	C,A;G;T	160,6;162;161	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3099	137.2	1	SNP	p	R87I	0	.	.	259	261	CGT	624	626	CGT	169;168;169	C,A;G;T	160,6;162;161	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3099	137.2	1	SNP	p	R87W	0	.	.	259	261	CGT	624	626	CGT	169;168;169	C,A;G;T	160,6;162;161	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3099	137.2	1	SNP	p	S88P	0	.	.	262	264	TCC	627	629	TCC	168;167;167	T;C;C	162;164;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3476	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2813	122.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1611	1613	GGC	185;184;183	G;G;C	184;182;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1265	1267	GCA	177;181;179	G;C;A,C	171;173;172,3	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1268	1270	ATC	179;180;179	A,C;T;C,G	175,1;176;170,3	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1280	1282	GTG	188;189;188	G,A;T,C;G,C,T	181,1;179,1;180,1,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1280	1282	GTG	188;189;188	G,A;T,C;G,C,T	181,1;179,1;180,1,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1784	1786	ACC	123;125;128	A;C;C	118;121;125	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1838	1840	GCG	148;150;148	G;C,G;G	142;132,1;141	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1838	1840	GCG	148;150;148	G;C,G;G	142;132,1;141	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1961	1963	AGC	115;115;116	A,G;G;C,T	110,2;113;113,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1970	1972	GGC	113;111;109	G,A;G;C	109,1;109;107	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3200	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2494	125.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1988	1990	CCG	83;83;84	C,G;C,A;G	74,2;73,1;74	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4784	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	2985	158.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1543	1545	CCG	169;168;167	C;C,T;G,C	153;158,7;158,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2252	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1764	126.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	499	499	C	160	C	147	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	110	112	AAT	11;12;12	A;A;T	11;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	113	115	AAT	13;13;13	A,G;A;T	12,1;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	137	139	GCA	12;12;13	G;C,T;A	12;11,1;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	160	162	GTA	9;8;8	G;T;A	8;7;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	166	168	AAC	8;8;8	A;A,G;C	8;7,1;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	.	MULTIPLE	709	711	AAC	170	174	TGGCG	8;8;11;12;15	T,A;G,C;G;C,A;G	7,1;7,1;11;11,1;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	D238A	NONSYN	712	714	GAT	176	178	GCT	18;19;22	G;C,T;T	17;17,1;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	236	238	TTA	36;36;36	T,G;T;A	34,2;36;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	281	283	CAT	27;27;25	C,G;A;T	24,2;26;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	284	286	AGT	25;25;25	A,G;G,A;T	23,2;23,2;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	238	porB1a	984	292	90.54	porB1a.l6.c30.ctg.2	377	19.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	293	295	TAC	25;25;25	T,C;A;C	23,2;25;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	283	285	GAA	163;164;165	G;A;A	161;160;162	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	571	573	GAT	177;176;177	G,A;A;T,G	168,4;174;170,3	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	598	600	GAA	194;196;198	G,C;A,G;A	182,6;188,3;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	694	696	TCA	185;183;181	T;C;A	180;180;181	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	823	825	GTC	168;168;171	G,A;T;C,G	160,3;165;166,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	835	837	TCT	168;169;171	T;C,T;T,C	163;163,5;169,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1153	1155	GCA	164;166;168	G;C,A;A	161;152,11;166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	1	SNP	p	G120K	1	.	.	358	360	AAG	529	531	AAG	177;177;176	A,G;A,G;G,T	170,3;172,3;169,3	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	1	SNP	p	D121N	0	.	.	361	363	GAC	532	534	GAC	172;174;176	G,A;A,C;C	166,3;167,3;169	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2210	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1362	157.5	1	SNP	p	A121D	1	.	.	361	363	GAC	532	534	GAC	172;174;176	G,A;A,C;C	166,3;167,3;169	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	190	93.19	porB3.l6.c30.ctg.3	283	3.9	0	.	p	.	0	V274F	NONSYN	820	822	GTT	20	22	TTT	7;7;7	T;T;T	0;0;0	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	190	93.19	porB3.l6.c30.ctg.3	283	3.9	0	.	p	.	0	A277fs	FSHIFT	829	829	G	29	29	G	7	G	0	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8220	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4845	167.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	936	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1106	83.3	1	SNP	p	V57M	1	.	.	169	171	ATG	528	530	ATG	192;194;194	A,G;T;G	189,1;189;190	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
